Additionally, elevated PGAM1 expression correlates with clinical features such as tumor grade, lymph node metastasis, and pathological staging, serving as an independent risk factor affecting prognosis. Here, PGAM1 is linked to metastatic malignant neoplasm in the lymph nodes.